
Autologous hematopoietic stem cell transplantation in progressive severe multiple sclerosis
Author(s) -
Awadh Kishor Pandit,
Kameshwar Prasad,
Tulika Seth
Publication year - 2015
Publication title -
annals of indian academy of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.427
H-Index - 31
eISSN - 1998-3549
pISSN - 0972-2327
DOI - 10.4103/0972-2327.165482
Subject(s) - medicine , multiple sclerosis , hematopoietic stem cell transplantation , stem cell , transplantation , mitoxantrone , stem cell therapy , population , oncology , surgery , immunology , chemotherapy , environmental health , biology , genetics
Multiple sclerosis (MS) is a chronic inflammatory disease of central nervous system (CNS), which is disabling and majorly involves younger population. Various available treatments in forms of immunomodulation are not very effective; however, stem cell transplantation seems to be promising in recent literature. The current case report is a novel evidence for autologous hematopoietic stem cell transplantation (HSCT) in progressive MS.